Kiran C. Patel, MD was until recently the Chairman and President of Freedom Health, Inc. Dr. Patel and also the Chairman and President of Optimum Healthcare, Inc. He is a Board-Certified cardiologist. Dr. Patel began his career in private practice. He quickly became recognized as a pre-eminent cardiologist and established a physician practice management company, which he grew to over 20 physicians and multiple locations. He is the founder of the Drs. Kiran and Pallavi Patel Family Foundation. Dr. Patel subsequently entered the managed care industry and was the Chairman of WellCare of Florida. While at WellCare, he acquired struggling HMOs in New York and Connecticut. Dr. Patel left WellCare in 2002. After that, Dr. Patel was under a non-compete agreement and thus became involved in healthcare informatics. He was a Member of Advisory Board of BelHealth Investment Partners, LLC. Among the honors and awards that he has received is the Ernst & Young Entrepreneur of the Year Award for the Southeast United States, Jefferson Award for Public Service-National Media Award, Community Leader Award-Community Development Corporation of Tampa, Lions Clubs International Academy Award for Humanitarian Service, and Ike Tribble Award from National Urban League. On New Year’s Day in 2007, Dr. Patel was honored with the “Glory of Gujarat” award from the Chief Minister of his home State in India. In May 2007, he received the Ellis Island Medal of Honor for Exceptional Immigrant Patriots. Dr. Patel completed his fellowship in Cardiology at Columbia University in 1982. He completed his residency in Internal Medicine in New Jersey after obtaining a Medical degree from Gujarat University in India and completed an internship in Africa. Dr. Patel studied under the British Educational System in Zambia and received a Diploma from Cambridge University in the United Kingdom. He also completed studies at the University of London.
James A McNulty is CEO of privately held MyMD Pharmaceuticals, Inc., which recently filed an IND for a novel immunometabolic regulator. He is Manager and CFO of Hopkins Capital Group, LLC, an affiliation of limited liability companies which engage in venture activities primarily in the development of pharmaceuticals. He is CFO of Defender Pharmaceuticals, Inc. and served as Secretary/Chief Compliance Officer for Hedgepath Pharmaceuticals, Inc. (OTC: HPPI) from 2013 through 2017, and since 2016 is a Director of CV Sciences, Inc. (OTC:CVSI www.cvsciences.com). Mr. McNulty was CFO of Biodelivery Sciences International, Inc. (NASDAQ: BDSI) from 2000 until his retirement from BDSI in 2014, Mr. McNulty has performed accounting and consulting services, including expert testimony as a Certified Public Accountant since 1975. He co-founded Pender McNulty & Newkirk, which became one of Florida’s largest regional CPA firms and was a founder/principal in two other CPA firms. He served as CFO of Star Scientific, Inc. and as CFO/COO of American Prescription Providers, Inc. and other affiliated companies. He served as a board member of privately held Quantum Technology Sciences, Inc. until its recent acquisition by Geospace Technologies. He is a published co-author (with Pat Summerall) of Business Golf, the Art of Building Relationships on the Links. Mr. McNulty is a graduate of the University of South Florida, a licensed CPA and is a member of the American and Florida Institutes of CPA’s. He also served several years as a board member of the Tampa Bay chapter of Financial Executives International.
Pat is a co-founder of Morphogenesis, Inc. and has served the Company as Chief Executive Officer since 2003. Pat also served as Morphogenesis’ Chief Operating Officer from 1996 until 2003. Pat previously served as Division Director of Cancer Molecular Biology at the Walt Disney Memorial Cancer Institute, where she initiated and led the multifaceted molecular biology, gene targeting, gene therapy, gene delivery, and universal stem cell projects. Pat holds degrees from the University of Florida in Anthropology, Plant Pathology, Immunology and Medical Microbiology with specialties in Hematology and Oncology and has held faculty positions at several Florida State Universities.
Michael is a co-founder of Morphogenesis, Inc. Michael received his PhD from the University of Surrey, UK, while working at the Animal Virus Research Institute (The Pirbright Institute). Michael came to the US as an NIH postdoctoral fellow at the University of Tennessee. Michael then served on the faculty of the Colleges of Veterinary Medicine at Auburn University and the University of Florida. Michael also worked as a senior scientist in the Division of Immunology and Cytokine Therapeutics of the Veterinary Infectious Disease Organization – Vaccine and Infectious Disease Organization (VIDO) of Canada. Michael also held a faculty position at the University of Florida in the College of Medicine and was Director of Research at the Walt Disney Memorial Cancer Institute. Michael has published extensively and is co-inventor on numerous US and world-wide patents. He has participated as a research consultant on a number of topics for the Biopharmaceutical Industry and for International and US agencies. Michael also served as a reviewer and as an Ad Hoc reviewer for a number of scientific journals.
David Bergmann is the President and Founder of NAECO, LLC (established 1999) and other technology ventures. NAECO has been recognized twice in the INC® 5000 list of fastest growing US private businesses and four-times nominated as Georgia Manufacturer of the Year. A Biotech investor since 2011, David has a 27-year career in technical product development, prototyping, manufacturing and marketing. Through both organic growth and acquisitions, he led NAECO’s expansion into the Aerospace, Military and Medical markets, and holds 13 intellectual properties. As a supplier and collaborator, David has supported dozens of product development efforts for companies ranging from small startups to international corporations. His company holds globally recognized Quality certifications in Medical, Aerospace and Industrial manufacturing. David earned a MS degree in Industrial and Systems Engineering, and a BS in Applied Mathematics from the University of Florida. In addition to serving on Morphogenesis’ board, David serves on the Board of the Fayette County Chamber of Commerce. David has been married for nearly 23 years to his sweetheart, Tracy.
Mr. J. P. Errico is a Co-Founded electroCore LLC in 2005 and serves as its Chairman and Principal Investor. Mr. Errico has also been Chief Science & Strategy Officer of electroCore LLC since July 21, 2016. He served as the Chief Executive Officer of electroCore LLC until July 21, 2016. He founded Spinecore, Inc. and served as its Chief Executive Officer until July 2004. Mr. Errico has co-founded a number of medical device companies, including Fastenetix, K2 Medical, AD-4 Pharma, E2, and SpineCore. He serves as a Director of electroCore, LLC. Mr. Errico trained as a patent attorney in New York and is the author of a treatise on international intellectual property law. Mr. Errico is a named inventor on more than 125 issued US patents and is a named inventor on more than 100 pending US applications. Additional patents and patent applications outside the US on which he is a named inventor number greater than 200. Mr. Errico received his undergraduate degree in aeronautical engineering from the Massachusetts Institute of Technology and worked at the Air Force National Laboratory, Lincoln Laboratories. He holds both law and mechanical/materials engineering graduate degrees from Duke University.
Dr. Staats was the founder of the division of Pain Medicine in the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins University, where he was the division chief and director for over a decade. In this capacity, he was the youngest major division chief in the history of Johns Hopkins Hospital and was the first anesthesiologist to obtain surgical standing at any academic university. Dr. Staats was also granted standing within the Department of Oncology at Johns Hopkins through his work in the treatment of cancer pain. In 2003, he became a founding partner in Premier Pain Centers in New Jersey which merged with National Spine and Pain Centers (NSPC), the largest pain practice in the United States. In 2005, Dr. Staats helped co-found electroCore with Mr. Errico. He is currently the chief medical officer of both NSPC and electroCore. He serves on the United States Health and Human Services Pain task force subcommittee assessing opioids in the context of pain and addiction.
Dr. Staats is boarded by the American Society of Anesthesiology, the American Board of Interventional Pain Physicians (ABIPP) and the World Institute of Pain (FIPP) and has received fellowship status from both the World Institute of Pain and the North American Neuromodulation Society. He is the Past President of (ASIPP), the American Society of Interventional Pain Physicians, the North American Neuromodulation Society (NANS), the Southern Pain Society the New Jersey Society of Interventional Pain Physicians (NJSIPP) and was the first chair of the American Society of Anesthesia’s committee on Interventional pain. He is currently chairman of the Board of Examination World Institute of Pain (WIP) and is on the Executive Board of the WIP. He has edited or co-authored 11 textbooks on pain medicine and written approximately four hundred articles, book chapters, and abstracts on neuromodulation and the diagnosis and management of complex pain problems. His publications have appeared in prominent journals including JAMA, Lancet, Anesthesiology, Pain Medicine and others. He has chaired hundreds of meetings devoted to pain and neuromodulation around the world.
Dr. Staats is the recipient of the President’s Distinguished Service Award and numerous additional awards from regional and state pain societies. He has received distinguished service awards from AAPM, ASIPP, NANS and NJSIPP, and the Raj award for excellence (2017) and the lifetime achievement award (2018) from the American Society of Interventional Pain Physicians.